title: Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease.
abstract: The quality of tissue imaging by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) depends on the effectiveness of the matrix deposition, especially for lipids that may dissolve in the solvent used for the matrix application. This article describes the use of an oscillating capillary nebulizer (OCN) to spray small droplets of matrix aerosol onto the sample surface for improved matrix homogeneity, reduced crystal size, and controlled solvent effects. This system was then applied to the analysis of histological slices of brains from mice with homozygous disruption of the hexb gene (hexb-/-), a model of Tay-Sachs and Sandhoff disease, versus the functionally normal heterozygote (hexb+/-) by imaging MALDI-MS. This allowed profiling and localization of many different lipid species, and of particular interest, ganglioside GM2, asialo-GM2 (GA2), and sulfatides (ST). The presence of these compounds was confirmed by analysis of brain extracts using electrospray ionization in conjunction with tandem mass spectrometry (MS/MS). The major fatty acid of the ceramide backbone of both GM2 and GA2 was identified as stearic acid (18:0) versus nervonic acid (24:1) for ST by both tissue-imaging MS and ESI-MS/MS. GM2 and GA2 were highly elevated in hexb-/- and were both localized in the granular cell region of the cerebellum. ST, however, was localized mainly in myelinated fiber (white matter) region of the cerebellum as well as in the brain stem with a relatively uniform distribution and had similar relative signal intensity for both hexb+/- and hexb-/- brain. It was also observed that there were distinct localizations for numerous other lipid subclasses; hence, imaging MALDI-MS could be used for "lipidomic" studies. These results illustrate the usefulness of tissue-imaging MALDI-MS with matrix deposition by OCN for histologic comparison of lipids in tissues such as brains from this mouse model of Tay-Sachs and Sandhoff disease.
authors.affiliation: School of Chemistry and Biochemistry, The Parker H. Petit Institute for Bioengineering and Bioscience, 315 Ferst Drive, Georgia Institute of Technology, Atlanta, Georgia 30332-0363, USA.
authors.forename: Yanfeng
authors.initials: Y
authors.lastname: Chen
authors.forename: Jeremy
authors.initials: J
authors.lastname: Allegood
authors.forename: Ying
authors.initials: Y
authors.lastname: Liu
authors.forename: Elaine
authors.initials: E
authors.lastname: Wang
authors.forename: Begoña
authors.initials: B
authors.lastname: Cachón-Gonzalez
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Cox
authors.forename: Alfred H
authors.initials: AH
authors.lastname: Merrill
authors.forename: M Cameron
authors.initials: MC
authors.lastname: Sullards
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry; D004195:Disease Models, Animal; D005678:G(M2) Ganglioside / Q000032:analysis / Q000378:metabolism; D005732:Gangliosides / Q000032:analysis / Q000378:metabolism; D050356:Lipid Metabolism; D008055:Lipids / Q000032:analysis*; D051379:Mice; D009330:Nebulizers and Vaporizers; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000295:instrumentation* / Q000379:methods*; D013107:Sphingolipids / Q000032:analysis / Q000378:metabolism; D013433:Sulfoglycosphingolipids / Q000032:analysis / Q000378:metabolism; D013661:Tay-Sachs Disease / Q000378:metabolism*
chemical_list: D005732:Gangliosides; D008055:Lipids; D013107:Sphingolipids; D013433:Sulfoglycosphingolipids; D005678:G(M2) Ganglioside; C038244:ganglio-N-triaosylceramide